June 2025, From the Field
On May 12, 2025, the U.S. and China significantly rolled back tariffs on each other’s goods for an initial 90-day period. The U.S. reduced tariffs on Chinese goods from 145% to 30%, while China cut retaliatory tariffs on U.S. goods from 125% to 10% for the period. Additionally, President Trump’s revised executive order lowered tariffs on small packages valued under USD800 from 120% to 54%. While further developments in trade talks are expected ahead, the truce was well received by the markets, with the MSCI China Index climbing 17% since April 7, 2025, lifting year-to-date returns to 15% (as of April 16, 2025).
Past performance is not a guarantee or a reliable indicator of future results.
Source: FactSet, MSCI, returns in U.S. dollars.
As of 30 May 2025.
As of 30 April 2025.
Sources: Financial data and analytics provider FactSet. Copyright 2025 FactSet. All Rights Reserved, MSCI, Goldman Sachs Global Investment Research.
At the expiry of the 90-day window, we might see further escalation or deescalation. Regardless of the outcome of the trade deal, several trends are emerging, poised to reshape the global economic landscape and redefine investment opportunities.
"Regardless of the outcome of the trade deal, several trends are emerging, poised to reshape the global economic landscape…"
The U.S. is advancing its reindustrialization agenda, with tariff policies as a cornerstone. This strategy prioritizes strategic sectors such as semiconductors, electric vehicles, pharmaceuticals, steel, and shipbuilding. As a result, global supply chains in these industries are undergoing significant disruption and reconfiguration. The highly integrated, globalized supply chain model is giving way to a more regionalized yet interconnected framework. This shift presents challenges for all economies, but those with robust domestic markets and comprehensive industrial ecosystems are better equipped to adapt.
With lingering uncertainties from tariffs, it’s helpful to assess their potential impact on the Chinese economy.
Over the past decade, China has implemented proactive measures to mitigate external pressures. The Belt and Road Initiative has broadened access to global markets, diversifying trade partnerships, while the “dual circulation” strategy has fortified domestic economic resilience. Additionally, breakthroughs in critical technologies have eased supply-side bottlenecks, and deleveraging in the financial and real estate sectors has reduced systemic risks, positioning China to better absorb potential shocks.
The economic impact from tariffs is moderated by China’s reduced reliance on U.S. markets. In 2024, exports to the U.S. (including re-exports) accounted for approximately 3% of China’s GDP, down from 6% in 2010, reflecting a significant shift in trade dynamics.
Sources: Financial data and analytics provider FactSet. Copyright 2025 FactSet. All Rights Reserved, MSCI, Goldman Sachs Global Investment Research. 2024 annual data.
At the corporate level, the impact of tariff escalation is limited for most Chinese firms, with U.S. exports comprising only around 1% of the average revenue of listed companies—one of the lowest U.S. exposures globally. Escalation may exacerbate slower economic growth, but firms are adapting by accelerating globalization strategies.
"At the corporate level, the impact of tariff escalation is limited for most Chinese firms…"
Since 2018, many have pivoted from export-focused models to globalized operations, a trend likely to intensify. Companies with advanced technologies and operational agility are well-placed to seize opportunities, even in a volatile trade environment, supporting long-term equity resilience.
1. Building a more balanced economy
Enhancing domestic consumption aligns with China’s internal needs and is essential in the current external environment. This transition will be supported by strengthening the social safety net, improving healthcare, and expanding educational opportunities. The investment focus is expected to shift from “hardware” (infrastructure) to “software” (human capital).
"Enhancing domestic consumption aligns with China’s internal needs…"
2. A stabilising property sector
The real estate sector is showing signs of stabilization, with housing starts declining by 68% from the peak in 2021, which had significantly impacted the overall economy. However, inventories in major cities are nearing normalized levels. While we do not anticipate a strong rebound, we do expect the negative impact to diminish over the next one to two years.
3. End market improvements
After several years of downturn, specific end markets are beginning to show improvement, particularly in construction machinery, wind power, automation, and railways.
1. Evolving consumer trends
The consumer market is undergoing a transformation. Selective businesses in traditional categories, such as dairies and beer, are seeing incremental improvement with companies’ self-help measures. Meanwhile, hotel chains and shopping malls are experiencing steady growth through market consolidation. Furthermore, we are witnessing the emergence of new consumption patterns, particularly in intellectual property, fresh beverages, and snacks, signaling a dynamic shift in consumer preferences and behaviors.
2. Technological innovation
While Deepseek has highlighted China’s capabilities in AI, rapid technological advancements have been occurring over the past few years and are expected to accelerate further. Although China faces constraints in computing power, we think that it is well-positioned for the application and commercialization of AI technologies. For instance, in the automotive sector, China has established strong leadership in electric vehicles (EVs) and is expected to potentially lead in autonomous driving. In biotechnology, China has transitioned from a generative market to an innovation powerhouse, with approximately 30%-40% of global biotech out-licensing originating from China in 2024.1
3. Dislocation opportunities
Market dislocation has presented bottom-up investors with opportunities to capitalize on indiscriminate sell-offs by acquiring export-related stocks that have been oversold.
Companies with forward-looking strategies and flexible approaches stand to gain market share as the market evolves. Staying calm and conducting objective fundamental analysis can help investors uncover undervalued investment opportunities in China with significant potential.
Seeking to identify rising stars in China’s sea change with a differentiated solution that goes beyond the top 100 China mega-cap companies.
1 Source: China Pharmaceutical Industry Research Development Association. As of 5 April 2025.
Additional Disclosures
Financial data and analytics provider FactSet. Copyright 2025 FactSet. All Rights Reserved.
MSCI and its affiliates and third-party sources and providers (collectively, “MSCI”) makes no express or implied warranties or representations and shall have no liability whatsoever with respect to any MSCI data contained herein. The MSCI data may not be further redistributed or used as a basis for other indices or any securities or financial products. This report is not approved, reviewed, or produced by MSCI. Historical MSCI data and analysis should not be taken as an indication or guarantee of any future performance analysis, forecast or prediction. None of the MSCI data is intended to constitute investment advice or a recommendation to make (or refrain from making) any kind of investment decision and may not be relied on as such.
Important Information
Where securities are mentioned, the specific securities identified and described are for informational purposes only and do not represent recommendations.
This material is being furnished for general informational purposes only. The material does not constitute or undertake to give advice of any nature, including fiduciary investment advice. Prospective investors are recommended to seek independent legal, financial and tax advice before making any investment decision. T. Rowe Price group of companies including T. Rowe Price Associates, Inc. and/or its affiliates receive revenue from T. Rowe Price investment products and services. Past performance is not a reliable indicator of future performance. Investment involves risks. The value of an investment and any income from it can go down as well as up. Investors may get back less than the amount invested.
The material does not constitute a distribution, an offer, an invitation, a personal or general recommendation or solicitation to sell or buy any securities in any jurisdiction or to conduct any particular investment activity. The material has not been reviewed by any regulatory authority in any jurisdiction.
Information and opinions presented have been obtained or derived from sources believed to be reliable and current; however, we cannot guarantee the sources’ accuracy or completeness. There is no guarantee that any forecasts made will come to pass. The views contained herein are as of the date written and are subject to change without notice; these views may differ from those of other T. Rowe Price group companies and/or associates. Under no circumstances should the material, in whole or in part, be copied or redistributed without consent from T. Rowe Price
The material is not intended for use by persons in jurisdictions which prohibit or restrict the distribution of the material and in certain countries the material is provided upon specific request.
Hong Kong—Issued by T. Rowe Price Hong Kong Limited, 6/F, Chater House, 8 Connaught Road Central, Hong Kong. T. Rowe Price Hong Kong Limited is licensed and regulated by the Securities & Futures Commission (“SFC”). This material has not been reviewed by the SFC.
Singapore—Issued by T. Rowe Price Singapore Private Ltd. (UEN 201021137E), 501 Orchard Road, #10-02 Wheelock Place, Singapore 238880. T. Rowe Price Singapore Private Ltd. is licensed and regulated by the Monetary Authority of Singapore. This advertisement or publication has not been reviewed by the Monetary Authority of Singapore.
© 2025 T. Rowe Price. All Rights Reserved. T. ROWE PRICE, INVEST WITH CONFIDENCE, the Bighorn Sheep design and related indicators (www.troweprice.com/en/intellectual-property) are trademarks of T. Rowe Price Group, Inc. All other trademarks are the property of their respective owners.